Claims for Patent: 4,985,360

Summary for Patent: 4,985,360

Title:	Novel bilirubin oxidase which has a substrate specifity to bilirubin, but not to biliverdin, catechol and hemin
Abstract:	A novel bilirubin oxidase is provided having a substrate specificity for bilirubin but not to, at least, biliverdin, catechol and hemin and which catalyzes the enzyme reaction between two moles of bilirubin and one mole of oxygen to yield two moles of biliverdin and two moles of water. A process is also provided for the production of said novel bilirubin oxidase, which comprises cultivating a bilirubin oxidase-producing fungus of the genus Penicillium in a culture medium and collecting the bilirubin oxidase from the culture mixture. A method of determining the content of bilirubin in a sample to be analyzed is further provided which comprises contacting the sample with the bilirubin oxidase to convert bilirubin in the sample into biliverdin and determining the amount of biliverdin formed or the amount of oxygen consumed therefor, as well as a method for removing bilirubin contained in a sample to be analyzed, which comprises contacting the sample with said novel bilirubin oxidase.
Inventor(s):	Takahashi; Mamoru (Shizuoka, JP), Imamura; Shigeyuki (Shizuoka, JP), Takada; Masaki (Shizuoka, JP)
Assignee:	Toyo Jozo Kabushiki Kaisha (Shizuoka, JP)
Application Number:	07/204,868
Patent Claims:	1. A bilirubin oxidase possessing a substrate specificity for bilirubin but not to biliverdin, catechol and hemin, said bilirubin oxidase catalyzing the enzyme reaction between two moles of bilirubin and one mole of oxygen to yield two moles of biliverdin and two moles of water, said bilirubin oxidase being in purified form. 2. A bilirubin oxidase according to claim 1, which exhibits the following physiochemical properties: 3. A process for the production of bilirubin oxidase, comprising cultivating a bilirubin oxidase-producing fungus of the strain Penicillium janthinellum M 5613 deposited at the Institute of Microbiological Industry and Technology of the Agency of Industrial Science and Technology Japan under deposition No. FERM BP-1674. 4. In a method for determining the content of bilirubin in a sample to be analyzed, comprising contacting the sample with bilirubin oxidase to convert bilirubin in the sample into biliverdin and subsequently determining the amount of biliverdin formed or the amount of oxygen consumed, the improvement specificity for bilirubin oxidase possesses a substrate specificity for bilirubin but not to biliverdin, catechol and hemin, said bilirubin oxidase catalyzing the enzyme reaction between two moles of bilirubin and one mole of oxygen to yield two moles of biliverdin and two moles of water. 5. The method of claim 4, wherein said bilirubin oxidase exhibits the following physiochemical properties: 6. A method for eliminating bilirubin contained in a sample to be analyzed, comprising contacting the sample with a bilirubin oxidase having a substrate specificity for bilirubin but not to biliverdin, catechol and hemin and catalyzing the enzyme reaction between two moles of bilirubin and one mole of oxygen to yield two moles of biliverdin and two moles of water. 7. The method of claim 6, wherein said bilirubin oxidase exhibits the following physiochemical properties:

Details for Patent 4,985,360

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2008-01-15